A personalized cancer vaccine could be available as soon as 2027. Here’s what we know

A breakthrough treatment for the deadliest form of skin cancer can cut a patient’s risk of recurrence or death nearly in half. The new scientific revelation is powered by an mRNA-based vaccine crafted with the technology behind both Pfizer and Moderna’s landmark Covid-19 shots. By using mRNA, the vaccine can be tailored to the genetic specifics of a specific patient’s skin cancer, fighting tumors much more effectively than generic traditional methods. “For decades, cancer treatment h...